Dapsone in the treatment of pemphigus vulgaris.

Pemphigus vulgaris: approach to treatment.

Dapsone in the treatment of pemphigus vulgaris: adverse effects and its importance as a corticosteroid sparing agent.

$Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris.$
Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris.

Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.

Management of Pemphigus Vulgaris.

Ocular involvement in pemphigus vulgaris.

Signalling pathways in pemphigus vulgaris.

Locations of acantholysis in pemphigus vulgaris and pemphigus foliaceus.

Radiotherapy-induced pemphigus vulgaris.

Regional anaesthesia in pemphigus vulgaris.

Pemphigus vulgaris following D-penicillamine.

[Esophageal involvement during pemphigus vulgaris].

Pemphigus vulgaris with tense bullae.

Pemphigus vulgaris localised exclusively to the penis.

Pemphigus vulgaris localized to the tongue.

Rapid transition from pemphigus vulgaris to pemphigus foliaceus.

Pemphigus vulgaris presented with cheilitis.

RECENT TRENDS IN THE MANAGEMENT OF PEMPHIGUS VULGARIS.

The dual nature of interleukin-10 in pemphigus vulgaris.

Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris.

Unsuspected involvement of the female genitalia in pemphigus vulgaris.

[Transition from pemphigus vulgaris to pemphigus foliaceus: a case report].

$Subcutaneous veltuzumab, a humanized anti-CD20 antibody, in the treatment of refractory pemphigus vulgaris.$
Subcutaneous veltuzumab, a humanized anti-CD20 antibody, in the treatment of refractory pemphigus vulgaris.

Successful treatment of pemphigus vulgaris with the extensive mucocutaneous lesions in an elderly patient.

Suggest Documents

Pemphigus vulgaris: approach to treatment.

Dapsone in the treatment of pemphigus vulgaris: adverse effects and its importance as a corticosteroid sparing agent.

Intralesional Rituximab in the Treatment of Refractory Oral Pemphigus Vulgaris.

Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.

Management of Pemphigus Vulgaris.

Ocular involvement in pemphigus vulgaris.

Signalling pathways in pemphigus vulgaris.

Locations of acantholysis in pemphigus vulgaris and pemphigus foliaceus.

Radiotherapy-induced pemphigus vulgaris.

Regional anaesthesia in pemphigus vulgaris.

Pemphigus vulgaris following D-penicillamine.

[Esophageal involvement during pemphigus vulgaris].

Pemphigus vulgaris with tense bullae.

Pemphigus vulgaris localised exclusively to the penis.

Pemphigus vulgaris localized to the tongue.

Rapid transition from pemphigus vulgaris to pemphigus foliaceus.

Pemphigus vulgaris presented with cheilitis.

RECENT TRENDS IN THE MANAGEMENT OF PEMPHIGUS VULGARIS.

The dual nature of interleukin-10 in pemphigus vulgaris.

Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris.

Unsuspected involvement of the female genitalia in pemphigus vulgaris.

[Transition from pemphigus vulgaris to pemphigus foliaceus: a case report].

Subcutaneous veltuzumab, a humanized anti-CD20 antibody, in the treatment of refractory pemphigus vulgaris.

Successful treatment of pemphigus vulgaris with the extensive mucocutaneous lesions in an elderly patient.

Dapsone in the treatment of pemphigus vulgaris.

Recommend Documents

Follow Us